| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biological Specimen Banks | 10 | 2018 | 711 | 3.050 |
Why?
|
| Genetic Research | 10 | 2017 | 174 | 2.770 |
Why?
|
| Genomics | 37 | 2024 | 5717 | 2.720 |
Why?
|
| Parents | 23 | 2023 | 3405 | 2.570 |
Why?
|
| Neonatal Screening | 15 | 2023 | 591 | 2.530 |
Why?
|
| Genetic Testing | 29 | 2023 | 3444 | 2.310 |
Why?
|
| Informed Consent | 10 | 2018 | 995 | 1.610 |
Why?
|
| Electronic Health Records | 16 | 2024 | 4468 | 1.290 |
Why?
|
| Genome | 8 | 2023 | 1807 | 1.280 |
Why?
|
| Information Dissemination | 8 | 2018 | 1099 | 1.270 |
Why?
|
| Disclosure | 7 | 2022 | 736 | 1.170 |
Why?
|
| Bioethical Issues | 2 | 2017 | 124 | 1.060 |
Why?
|
| Rare Diseases | 6 | 2023 | 553 | 1.000 |
Why?
|
| Research Subjects | 4 | 2018 | 239 | 0.910 |
Why?
|
| Comprehension | 4 | 2017 | 610 | 0.890 |
Why?
|
| Confidentiality | 3 | 2019 | 612 | 0.870 |
Why?
|
| Patient Preference | 4 | 2018 | 889 | 0.810 |
Why?
|
| Genetic Counseling | 5 | 2022 | 600 | 0.730 |
Why?
|
| Death, Sudden | 3 | 2022 | 302 | 0.700 |
Why?
|
| Genetic Privacy | 3 | 2017 | 60 | 0.670 |
Why?
|
| Genetics, Medical | 6 | 2019 | 338 | 0.650 |
Why?
|
| Databases, Genetic | 7 | 2017 | 1783 | 0.630 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2021 | 587 | 0.630 |
Why?
|
| Truth Disclosure | 2 | 2019 | 436 | 0.620 |
Why?
|
| Attitude to Health | 4 | 2019 | 2052 | 0.610 |
Why?
|
| Family | 5 | 2021 | 3147 | 0.570 |
Why?
|
| Depression, Postpartum | 1 | 2021 | 340 | 0.570 |
Why?
|
| Population Groups | 6 | 2023 | 209 | 0.550 |
Why?
|
| Cryopyrin-Associated Periodic Syndromes | 1 | 2015 | 16 | 0.540 |
Why?
|
| Genes, BRCA2 | 1 | 2019 | 618 | 0.520 |
Why?
|
| Biomedical Research | 8 | 2018 | 3309 | 0.500 |
Why?
|
| Personal Satisfaction | 2 | 2018 | 643 | 0.490 |
Why?
|
| Vitamin D Deficiency | 3 | 2021 | 1343 | 0.490 |
Why?
|
| Child | 58 | 2023 | 77709 | 0.480 |
Why?
|
| Hypophosphatemia, Familial | 3 | 2001 | 34 | 0.480 |
Why?
|
| Decision Making | 6 | 2022 | 3888 | 0.480 |
Why?
|
| Arm Injuries | 1 | 2015 | 160 | 0.470 |
Why?
|
| Genome, Human | 10 | 2023 | 4420 | 0.470 |
Why?
|
| Physical Fitness | 2 | 2014 | 732 | 0.450 |
Why?
|
| Public Opinion | 1 | 2017 | 477 | 0.440 |
Why?
|
| Age of Onset | 2 | 2019 | 3270 | 0.430 |
Why?
|
| Conditioning, Classical | 1 | 2015 | 366 | 0.430 |
Why?
|
| Hand Injuries | 1 | 2015 | 242 | 0.430 |
Why?
|
| Sudden Infant Death | 4 | 2020 | 291 | 0.430 |
Why?
|
| Orthopedics | 1 | 2021 | 904 | 0.430 |
Why?
|
| Infant, Newborn | 26 | 2023 | 25628 | 0.420 |
Why?
|
| Medical History Taking | 1 | 2016 | 784 | 0.420 |
Why?
|
| Exercise Therapy | 2 | 2020 | 904 | 0.420 |
Why?
|
| Musculoskeletal Diseases | 2 | 2014 | 581 | 0.400 |
Why?
|
| Seizures, Febrile | 1 | 2012 | 111 | 0.380 |
Why?
|
| Humans | 141 | 2024 | 744366 | 0.370 |
Why?
|
| Sequence Analysis, DNA | 8 | 2019 | 4805 | 0.350 |
Why?
|
| Health Education | 3 | 2024 | 1056 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 12 | 2021 | 17446 | 0.330 |
Why?
|
| Cerebral Palsy | 2 | 2004 | 459 | 0.320 |
Why?
|
| Guidelines as Topic | 2 | 2014 | 1405 | 0.310 |
Why?
|
| Culture | 1 | 2012 | 633 | 0.310 |
Why?
|
| Child, Preschool | 27 | 2022 | 41005 | 0.300 |
Why?
|
| Adult | 56 | 2023 | 214052 | 0.300 |
Why?
|
| Motivation | 3 | 2022 | 1971 | 0.290 |
Why?
|
| Pediatrics | 6 | 2022 | 3475 | 0.290 |
Why?
|
| Female | 78 | 2023 | 380193 | 0.290 |
Why?
|
| Sleep | 1 | 2022 | 4622 | 0.290 |
Why?
|
| Immunoglobulin Fc Fragments | 2 | 2019 | 279 | 0.290 |
Why?
|
| Cytochrome P-450 CYP2D6 | 2 | 2017 | 106 | 0.280 |
Why?
|
| Patient Satisfaction | 2 | 2017 | 3395 | 0.280 |
Why?
|
| Bone Development | 2 | 2007 | 483 | 0.280 |
Why?
|
| Parental Consent | 2 | 2018 | 62 | 0.280 |
Why?
|
| Pedigree | 4 | 2012 | 4642 | 0.280 |
Why?
|
| Male | 72 | 2023 | 350115 | 0.270 |
Why?
|
| Genetic Variation | 6 | 2019 | 6542 | 0.270 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3589 | 0.250 |
Why?
|
| Language Development Disorders | 2 | 2020 | 196 | 0.240 |
Why?
|
| Acidosis, Lactic | 2 | 2015 | 142 | 0.240 |
Why?
|
| Ethics Committees, Research | 4 | 2023 | 194 | 0.230 |
Why?
|
| Graves Disease | 1 | 2005 | 242 | 0.230 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 4639 | 0.230 |
Why?
|
| Chondroitinsulfatases | 1 | 2023 | 16 | 0.230 |
Why?
|
| Walking | 2 | 2014 | 1180 | 0.220 |
Why?
|
| National Human Genome Research Institute (U.S.) | 3 | 2016 | 23 | 0.220 |
Why?
|
| Adolescent | 34 | 2022 | 85779 | 0.220 |
Why?
|
| Research Design | 1 | 2018 | 5984 | 0.210 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2019 | 3595 | 0.210 |
Why?
|
| Infant | 21 | 2022 | 35134 | 0.200 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2012 | 615 | 0.200 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2004 | 231 | 0.200 |
Why?
|
| Locomotion | 1 | 2004 | 378 | 0.200 |
Why?
|
| Vital Statistics | 1 | 2021 | 34 | 0.200 |
Why?
|
| Osteoarthritis, Knee | 3 | 2020 | 1222 | 0.200 |
Why?
|
| Health Status | 1 | 2014 | 4034 | 0.200 |
Why?
|
| Hospitals, Pediatric | 3 | 2016 | 1775 | 0.200 |
Why?
|
| Genome-Wide Association Study | 3 | 2017 | 12262 | 0.200 |
Why?
|
| Arthralgia | 3 | 2016 | 456 | 0.190 |
Why?
|
| Immunoglobulin G | 3 | 2019 | 4561 | 0.190 |
Why?
|
| Alcohol Drinking | 2 | 2021 | 3966 | 0.190 |
Why?
|
| Blepharophimosis | 1 | 2020 | 22 | 0.190 |
Why?
|
| Pyrophosphatases | 1 | 2020 | 137 | 0.180 |
Why?
|
| DNA Copy Number Variations | 3 | 2021 | 1941 | 0.180 |
Why?
|
| Pharmacogenetics | 4 | 2019 | 674 | 0.180 |
Why?
|
| Patient Access to Records | 2 | 2014 | 118 | 0.180 |
Why?
|
| Personal Autonomy | 2 | 2019 | 298 | 0.170 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2020 | 197 | 0.170 |
Why?
|
| Bone Diseases | 4 | 2009 | 416 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2017 | 780 | 0.170 |
Why?
|
| Biotinidase | 1 | 2018 | 19 | 0.170 |
Why?
|
| Communication | 4 | 2024 | 3750 | 0.160 |
Why?
|
| Phenotype | 13 | 2022 | 16367 | 0.160 |
Why?
|
| Patient Rights | 2 | 2016 | 126 | 0.160 |
Why?
|
| Stillbirth | 1 | 2021 | 346 | 0.160 |
Why?
|
| Thalassemia | 2 | 2009 | 273 | 0.160 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 399 | 0.160 |
Why?
|
| Boston | 4 | 2016 | 9312 | 0.160 |
Why?
|
| Sodium Channels | 1 | 2020 | 349 | 0.160 |
Why?
|
| Censuses | 1 | 2019 | 200 | 0.150 |
Why?
|
| Middle Aged | 28 | 2023 | 213390 | 0.150 |
Why?
|
| Mutation | 10 | 2020 | 29786 | 0.150 |
Why?
|
| Adenosylmethionine Decarboxylase | 3 | 1995 | 11 | 0.150 |
Why?
|
| Binding Sites, Antibody | 1 | 2017 | 349 | 0.150 |
Why?
|
| Vocabulary | 1 | 2018 | 169 | 0.150 |
Why?
|
| Proteins | 4 | 2001 | 6100 | 0.150 |
Why?
|
| Duty to Recontact | 1 | 2016 | 20 | 0.150 |
Why?
|
| Diagnosis | 1 | 2018 | 154 | 0.150 |
Why?
|
| Bone and Bones | 2 | 2009 | 2576 | 0.150 |
Why?
|
| United States | 17 | 2021 | 69872 | 0.150 |
Why?
|
| Pregnant Women | 1 | 2021 | 568 | 0.140 |
Why?
|
| Infant Mortality | 1 | 2021 | 754 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2021 | 707 | 0.140 |
Why?
|
| Tooth Eruption | 1 | 1995 | 30 | 0.140 |
Why?
|
| Immersion | 1 | 2015 | 34 | 0.140 |
Why?
|
| Informed Consent By Minors | 1 | 2015 | 7 | 0.130 |
Why?
|
| Dental Pulp Cavity | 1 | 1995 | 34 | 0.130 |
Why?
|
| Cytochrome Reductases | 1 | 2015 | 9 | 0.130 |
Why?
|
| Health | 1 | 2019 | 394 | 0.130 |
Why?
|
| Tooth Abnormalities | 1 | 1995 | 54 | 0.130 |
Why?
|
| Craniofacial Abnormalities | 1 | 2018 | 315 | 0.130 |
Why?
|
| Anticipation, Psychological | 1 | 2016 | 87 | 0.130 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 1996 | 119 | 0.130 |
Why?
|
| Rewarming | 1 | 2015 | 61 | 0.130 |
Why?
|
| Metabolic Equivalent | 1 | 2014 | 14 | 0.130 |
Why?
|
| Publications | 1 | 2018 | 195 | 0.130 |
Why?
|
| Adaptation, Psychological | 3 | 2018 | 2575 | 0.130 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 598 | 0.130 |
Why?
|
| Mitochondria, Muscle | 1 | 1996 | 171 | 0.130 |
Why?
|
| GTPase-Activating Proteins | 1 | 2018 | 498 | 0.130 |
Why?
|
| Professional Role | 1 | 2018 | 306 | 0.130 |
Why?
|
| Genetics | 1 | 2015 | 112 | 0.120 |
Why?
|
| Privacy | 1 | 2017 | 238 | 0.120 |
Why?
|
| Data Collection | 2 | 2014 | 3339 | 0.120 |
Why?
|
| Sequence Deletion | 2 | 2013 | 1525 | 0.120 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1996 | 648 | 0.120 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2013 | 26 | 0.120 |
Why?
|
| Carney Complex | 1 | 2013 | 17 | 0.120 |
Why?
|
| Liver Function Tests | 1 | 2015 | 528 | 0.120 |
Why?
|
| Receptors, Fc | 1 | 2017 | 541 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 1 | 1996 | 481 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1851 | 0.120 |
Why?
|
| Down Syndrome | 1 | 2022 | 880 | 0.120 |
Why?
|
| Concept Formation | 1 | 2015 | 158 | 0.120 |
Why?
|
| Uncertainty | 2 | 2018 | 735 | 0.120 |
Why?
|
| Exons | 5 | 2020 | 2439 | 0.120 |
Why?
|
| Life Style | 1 | 2005 | 3835 | 0.120 |
Why?
|
| Neoplasms, Connective Tissue | 1 | 2013 | 40 | 0.110 |
Why?
|
| Autopsy | 2 | 2020 | 1020 | 0.110 |
Why?
|
| Autistic Disorder | 3 | 2013 | 1185 | 0.110 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 4 | 2001 | 17 | 0.110 |
Why?
|
| Adrenal Insufficiency | 1 | 2015 | 184 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2014 | 12721 | 0.110 |
Why?
|
| Ethics, Research | 1 | 2015 | 191 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2022 | 2917 | 0.110 |
Why?
|
| Vitamins | 1 | 2021 | 1623 | 0.110 |
Why?
|
| Disease | 1 | 2019 | 680 | 0.110 |
Why?
|
| Societies, Scientific | 1 | 2014 | 220 | 0.110 |
Why?
|
| Young Adult | 13 | 2017 | 56429 | 0.110 |
Why?
|
| Access to Information | 1 | 2016 | 320 | 0.110 |
Why?
|
| Laboratories | 1 | 2016 | 463 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2018 | 1364 | 0.110 |
Why?
|
| Cataract | 2 | 2015 | 834 | 0.110 |
Why?
|
| Incidental Findings | 2 | 2016 | 689 | 0.100 |
Why?
|
| Rett Syndrome | 1 | 2014 | 165 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2013 | 437 | 0.100 |
Why?
|
| Cold Temperature | 1 | 2015 | 772 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2020 | 1541 | 0.100 |
Why?
|
| Knee Injuries | 2 | 2010 | 490 | 0.100 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 501 | 0.100 |
Why?
|
| Enchondromatosis | 1 | 2011 | 14 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 1912 | 0.100 |
Why?
|
| Mitochondrial Diseases | 1 | 2015 | 320 | 0.100 |
Why?
|
| Growth Disorders | 3 | 2009 | 645 | 0.100 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2011 | 29 | 0.100 |
Why?
|
| Osteotomy | 2 | 1994 | 822 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 9647 | 0.100 |
Why?
|
| Peer Review, Research | 1 | 2014 | 329 | 0.100 |
Why?
|
| Patient Participation | 2 | 2018 | 1457 | 0.090 |
Why?
|
| Cause of Death | 1 | 2021 | 3582 | 0.090 |
Why?
|
| Psychiatry | 1 | 2023 | 1695 | 0.090 |
Why?
|
| Models, Psychological | 1 | 2015 | 811 | 0.090 |
Why?
|
| Mothers | 1 | 2021 | 2165 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2018 | 8319 | 0.090 |
Why?
|
| Child Welfare | 1 | 2014 | 523 | 0.090 |
Why?
|
| Femur | 2 | 1994 | 1297 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2011 | 234 | 0.090 |
Why?
|
| Pyruvates | 1 | 1989 | 87 | 0.090 |
Why?
|
| Patient Selection | 2 | 2019 | 4216 | 0.090 |
Why?
|
| Carboxy-Lyases | 1 | 1989 | 90 | 0.090 |
Why?
|
| Enzyme Precursors | 1 | 1989 | 176 | 0.090 |
Why?
|
| Vitamin D | 2 | 2021 | 3224 | 0.090 |
Why?
|
| Risk Assessment | 6 | 2023 | 23336 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 2018 | 1456 | 0.090 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 5856 | 0.090 |
Why?
|
| Glycosylation | 3 | 2019 | 1128 | 0.090 |
Why?
|
| Documentation | 1 | 2015 | 871 | 0.090 |
Why?
|
| Muscle Contraction | 2 | 1994 | 1235 | 0.090 |
Why?
|
| Norway | 3 | 2014 | 448 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2010 | 354 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2018 | 2241 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2018 | 1164 | 0.080 |
Why?
|
| Follow-Up Studies | 9 | 2020 | 39052 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2021 | 2408 | 0.080 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2010 | 322 | 0.080 |
Why?
|
| Language | 1 | 2018 | 1471 | 0.080 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 12961 | 0.080 |
Why?
|
| INDEL Mutation | 1 | 2009 | 279 | 0.080 |
Why?
|
| Health Personnel | 1 | 2022 | 3219 | 0.080 |
Why?
|
| Smoking | 1 | 2005 | 8987 | 0.080 |
Why?
|
| Postpartum Period | 1 | 2014 | 1086 | 0.080 |
Why?
|
| Osteomalacia | 2 | 2013 | 53 | 0.080 |
Why?
|
| Attitude of Health Personnel | 2 | 2019 | 3841 | 0.080 |
Why?
|
| Age Factors | 6 | 2019 | 18373 | 0.080 |
Why?
|
| Activities of Daily Living | 2 | 2014 | 2419 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 4 | 2019 | 7282 | 0.080 |
Why?
|
| Osteochondrodysplasias | 1 | 2009 | 183 | 0.080 |
Why?
|
| TRPV Cation Channels | 1 | 2009 | 237 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2016 | 2682 | 0.070 |
Why?
|
| Aged | 16 | 2023 | 163288 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2011 | 372 | 0.070 |
Why?
|
| Focus Groups | 1 | 2012 | 1321 | 0.070 |
Why?
|
| Densitometry | 1 | 2007 | 156 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1707 | 0.070 |
Why?
|
| Hypothermia | 1 | 1988 | 189 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1677 | 0.070 |
Why?
|
| Vesicular Transport Proteins | 1 | 2009 | 377 | 0.070 |
Why?
|
| Mutation, Missense | 2 | 2009 | 2566 | 0.070 |
Why?
|
| Exercise Test | 1 | 2014 | 2073 | 0.070 |
Why?
|
| Bone Neoplasms | 2 | 2013 | 2530 | 0.070 |
Why?
|
| Genetic Linkage | 3 | 2011 | 2421 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 2016 | 0.070 |
Why?
|
| Chromosome Deletion | 1 | 2010 | 1401 | 0.070 |
Why?
|
| Oxymetazoline | 1 | 1985 | 5 | 0.070 |
Why?
|
| Endocrine System Diseases | 1 | 2008 | 248 | 0.070 |
Why?
|
| Phosphates | 2 | 2001 | 785 | 0.070 |
Why?
|
| Motor Activity | 2 | 2014 | 2715 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 9955 | 0.060 |
Why?
|
| Bone Density | 3 | 2009 | 3468 | 0.060 |
Why?
|
| Research Personnel | 2 | 2023 | 573 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2018 | 3208 | 0.060 |
Why?
|
| X Chromosome | 2 | 1998 | 814 | 0.060 |
Why?
|
| Genetic Loci | 1 | 2013 | 2575 | 0.060 |
Why?
|
| Emotions | 1 | 2016 | 2659 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 1081 | 0.060 |
Why?
|
| Massachusetts | 1 | 2017 | 8662 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 20824 | 0.060 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2023 | 17 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 3922 | 0.060 |
Why?
|
| Public Health | 1 | 2017 | 2602 | 0.060 |
Why?
|
| Self Report | 1 | 2014 | 3553 | 0.060 |
Why?
|
| Minority Groups | 2 | 2023 | 1221 | 0.060 |
Why?
|
| Mental Disorders | 1 | 2023 | 6598 | 0.060 |
Why?
|
| Hospitals | 1 | 2017 | 3954 | 0.060 |
Why?
|
| Primary Health Care | 2 | 2018 | 4557 | 0.060 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2004 | 111 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 7785 | 0.050 |
Why?
|
| Hormones | 1 | 2007 | 889 | 0.050 |
Why?
|
| Introns | 3 | 2009 | 992 | 0.050 |
Why?
|
| Diphosphonates | 1 | 2007 | 623 | 0.050 |
Why?
|
| Prospective Studies | 7 | 2023 | 53290 | 0.050 |
Why?
|
| North Dakota | 1 | 2021 | 14 | 0.050 |
Why?
|
| Knee Joint | 3 | 2016 | 1680 | 0.050 |
Why?
|
| South Dakota | 1 | 2021 | 30 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 4839 | 0.050 |
Why?
|
| Radiography | 4 | 2016 | 7023 | 0.050 |
Why?
|
| Antiporters | 1 | 2023 | 277 | 0.050 |
Why?
|
| Siblings | 2 | 2019 | 854 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 15520 | 0.050 |
Why?
|
| Depression | 1 | 2021 | 7759 | 0.050 |
Why?
|
| Endocrinology | 1 | 2008 | 443 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1989 | 1988 | 0.050 |
Why?
|
| Cohort Studies | 7 | 2021 | 40559 | 0.050 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2023 | 440 | 0.050 |
Why?
|
| Polymorphism, Genetic | 2 | 2010 | 4328 | 0.050 |
Why?
|
| Genotype | 4 | 2015 | 12952 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2001 | 4185 | 0.050 |
Why?
|
| Tooth Diseases | 1 | 2001 | 77 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 3677 | 0.050 |
Why?
|
| Forecasting | 2 | 2021 | 2951 | 0.050 |
Why?
|
| Genetic Association Studies | 3 | 2015 | 2703 | 0.050 |
Why?
|
| Risk Factors | 6 | 2023 | 72296 | 0.050 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 1998 | 335 | 0.050 |
Why?
|
| Chromosome Mapping | 2 | 2021 | 4740 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2004 | 1185 | 0.050 |
Why?
|
| Anxiety | 1 | 2015 | 4293 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 1988 | 1178 | 0.050 |
Why?
|
| Athletic Injuries | 1 | 2010 | 1154 | 0.050 |
Why?
|
| Nuclear Family | 1 | 2001 | 318 | 0.050 |
Why?
|
| Osteophyte | 1 | 2020 | 45 | 0.050 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2004 | 324 | 0.050 |
Why?
|
| Glycogen Storage Disease | 1 | 1999 | 41 | 0.040 |
Why?
|
| Physicians | 1 | 2018 | 4567 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2015 | 767 | 0.040 |
Why?
|
| Facies | 1 | 2020 | 197 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2014 | 9145 | 0.040 |
Why?
|
| Algorithms | 2 | 2019 | 13882 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2021 | 77460 | 0.040 |
Why?
|
| Physical Therapy Modalities | 2 | 2020 | 550 | 0.040 |
Why?
|
| Brain Diseases | 1 | 1988 | 1563 | 0.040 |
Why?
|
| Imidazoles | 1 | 1985 | 1206 | 0.040 |
Why?
|
| Escherichia coli | 2 | 1995 | 4217 | 0.040 |
Why?
|
| Syndrome | 2 | 2018 | 3252 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2015 | 21748 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2014 | 9849 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 335 | 0.040 |
Why?
|
| Symporters | 1 | 2001 | 361 | 0.040 |
Why?
|
| Hypophosphatemia | 1 | 1998 | 85 | 0.040 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 13991 | 0.040 |
Why?
|
| Thigh | 2 | 2001 | 247 | 0.040 |
Why?
|
| Harm Reduction | 1 | 2019 | 129 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 1985 | 1416 | 0.040 |
Why?
|
| Tendons | 1 | 2001 | 548 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2007 | 1916 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2021 | 747 | 0.040 |
Why?
|
| Genomic Structural Variation | 1 | 2017 | 64 | 0.040 |
Why?
|
| Cytogenetics | 1 | 1997 | 203 | 0.040 |
Why?
|
| Parenting | 1 | 2022 | 679 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2001 | 1793 | 0.040 |
Why?
|
| Base Sequence | 4 | 2017 | 12797 | 0.030 |
Why?
|
| Tooth Eruption, Ectopic | 1 | 1995 | 6 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2018 | 230 | 0.030 |
Why?
|
| Human Rights | 1 | 2019 | 307 | 0.030 |
Why?
|
| South Africa | 1 | 2021 | 1731 | 0.030 |
Why?
|
| Odontometry | 1 | 1995 | 29 | 0.030 |
Why?
|
| Disease Management | 2 | 2018 | 2460 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2016 | 256 | 0.030 |
Why?
|
| Morocco | 1 | 2015 | 28 | 0.030 |
Why?
|
| Quality of Life | 2 | 2014 | 12802 | 0.030 |
Why?
|
| Cuspid | 1 | 1995 | 58 | 0.030 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2015 | 32 | 0.030 |
Why?
|
| Serotonin | 2 | 2010 | 1017 | 0.030 |
Why?
|
| Nurses | 1 | 2005 | 2462 | 0.030 |
Why?
|
| Employment | 1 | 2002 | 1132 | 0.030 |
Why?
|
| Disease Progression | 2 | 2020 | 13286 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2010 | 7730 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1997 | 396 | 0.030 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 1997 | 311 | 0.030 |
Why?
|
| Sex Ratio | 1 | 1995 | 110 | 0.030 |
Why?
|
| Glucuronosyltransferase | 1 | 2015 | 128 | 0.030 |
Why?
|
| Ankle Injuries | 1 | 1999 | 331 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2014 | 12244 | 0.030 |
Why?
|
| Waiting Lists | 1 | 1999 | 692 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1996 | 424 | 0.030 |
Why?
|
| Sex Factors | 2 | 2014 | 10400 | 0.030 |
Why?
|
| Cross-Sectional Studies | 4 | 2014 | 25039 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2014 | 6621 | 0.030 |
Why?
|
| Knowledge Bases | 1 | 2014 | 85 | 0.030 |
Why?
|
| Spinal Diseases | 1 | 1999 | 538 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2015 | 270 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1997 | 4320 | 0.030 |
Why?
|
| Tooth | 1 | 1995 | 207 | 0.030 |
Why?
|
| Health Surveys | 1 | 2004 | 4036 | 0.030 |
Why?
|
| Leg Length Inequality | 1 | 1994 | 55 | 0.030 |
Why?
|
| Bilirubin | 1 | 2015 | 425 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 908 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2023 | 2269 | 0.030 |
Why?
|
| Clinical Trials as Topic | 3 | 2016 | 7914 | 0.030 |
Why?
|
| Research Report | 1 | 2016 | 355 | 0.030 |
Why?
|
| Prevalence | 3 | 2021 | 15221 | 0.030 |
Why?
|
| Consanguinity | 1 | 2015 | 454 | 0.030 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 102 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 845 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2010 | 3587 | 0.030 |
Why?
|
| Adenoma | 1 | 2004 | 2174 | 0.030 |
Why?
|
| Financing, Organized | 1 | 2014 | 202 | 0.030 |
Why?
|
| Biological Transport | 1 | 1997 | 2120 | 0.030 |
Why?
|
| Professional-Family Relations | 1 | 2016 | 482 | 0.030 |
Why?
|
| Polyamines | 1 | 1992 | 120 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 867 | 0.030 |
Why?
|
| Logistic Models | 2 | 2009 | 13409 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 2804 | 0.030 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2013 | 151 | 0.030 |
Why?
|
| Patients | 1 | 2018 | 900 | 0.030 |
Why?
|
| Penetrance | 1 | 2013 | 381 | 0.030 |
Why?
|
| Software | 2 | 2016 | 4441 | 0.020 |
Why?
|
| Linear Models | 2 | 2014 | 5953 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1184 | 0.020 |
Why?
|
| Absorptiometry, Photon | 2 | 2009 | 1725 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2014 | 497 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 2795 | 0.020 |
Why?
|
| Food, Fortified | 1 | 1992 | 191 | 0.020 |
Why?
|
| Perception | 1 | 2017 | 1198 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1655 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2015 | 1997 | 0.020 |
Why?
|
| Thyroid Neoplasms | 1 | 2004 | 2282 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2017 | 781 | 0.020 |
Why?
|
| Survivors | 1 | 2020 | 2291 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2213 | 0.020 |
Why?
|
| Health Promotion | 1 | 2022 | 2205 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 3020 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2014 | 694 | 0.020 |
Why?
|
| Spinal Fusion | 1 | 1999 | 1241 | 0.020 |
Why?
|
| DNA Primers | 2 | 2009 | 2891 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2014 | 592 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1989 | 427 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1989 | 475 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1997 | 1660 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 2031 | 0.020 |
Why?
|
| Milk | 1 | 1992 | 450 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2015 | 1534 | 0.020 |
Why?
|
| Pregnancy | 2 | 2021 | 29144 | 0.020 |
Why?
|
| Somatomedins | 1 | 2009 | 192 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 457 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1995 | 3508 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 684 | 0.020 |
Why?
|
| Sports | 1 | 1995 | 688 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 2009 | 243 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1504 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2887 | 0.020 |
Why?
|
| Karyotyping | 1 | 2010 | 1243 | 0.020 |
Why?
|
| Counseling | 1 | 2015 | 1523 | 0.020 |
Why?
|
| Hippocampus | 1 | 2020 | 3675 | 0.020 |
Why?
|
| Tibia | 1 | 2013 | 1077 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2015 | 2740 | 0.020 |
Why?
|
| Joints | 1 | 2009 | 327 | 0.020 |
Why?
|
| Incidence | 1 | 2005 | 20952 | 0.020 |
Why?
|
| Growth Hormone | 1 | 2009 | 705 | 0.020 |
Why?
|
| Ferritins | 1 | 2009 | 590 | 0.020 |
Why?
|
| California | 1 | 2010 | 1402 | 0.020 |
Why?
|
| Reference Values | 1 | 2014 | 4982 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2715 | 0.020 |
Why?
|
| Genes | 1 | 1989 | 1893 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 3001 | 0.020 |
Why?
|
| Body Height | 1 | 1992 | 1578 | 0.020 |
Why?
|
| Bone Remodeling | 1 | 2009 | 575 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5321 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2001 | 4925 | 0.020 |
Why?
|
| Medical Records | 1 | 2010 | 1413 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2009 | 6171 | 0.020 |
Why?
|
| Plasmids | 1 | 1989 | 2308 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 15535 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3921 | 0.010 |
Why?
|
| Animals | 6 | 2009 | 168768 | 0.010 |
Why?
|
| Social Behavior | 1 | 2010 | 1127 | 0.010 |
Why?
|
| Organ Size | 1 | 2009 | 2251 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2013 | 4222 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2009 | 1117 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2005 | 370 | 0.010 |
Why?
|
| RNA, Messenger | 3 | 2009 | 13035 | 0.010 |
Why?
|
| Exercise | 2 | 1999 | 5615 | 0.010 |
Why?
|
| Haplotypes | 1 | 2009 | 2779 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2011 | 2751 | 0.010 |
Why?
|
| Hypogonadism | 1 | 2009 | 799 | 0.010 |
Why?
|
| Age Distribution | 1 | 2009 | 2902 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 2009 | 1800 | 0.010 |
Why?
|
| Calcitonin | 1 | 2004 | 336 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19905 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2012 | 3493 | 0.010 |
Why?
|
| Spinal Fractures | 1 | 2009 | 696 | 0.010 |
Why?
|
| Mitochondria | 1 | 2015 | 3514 | 0.010 |
Why?
|
| Kinetics | 1 | 1989 | 6476 | 0.010 |
Why?
|
| Comorbidity | 1 | 2016 | 10388 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 431 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type II | 1 | 2001 | 1 | 0.010 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins | 1 | 2001 | 7 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 2001 | 92 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4751 | 0.010 |
Why?
|
| Gene Expression | 2 | 1995 | 7798 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 18111 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2001 | 347 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15078 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 1205 | 0.010 |
Why?
|
| Glycogen Debranching Enzyme System | 1 | 1999 | 5 | 0.010 |
Why?
|
| Phosphorylase Kinase | 1 | 1999 | 10 | 0.010 |
Why?
|
| Phosphorylases | 1 | 1999 | 17 | 0.010 |
Why?
|
| Rupture | 1 | 2001 | 433 | 0.010 |
Why?
|
| Glycogen Synthase | 1 | 1999 | 62 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1997 | 7882 | 0.010 |
Why?
|
| Colchicine | 1 | 2001 | 244 | 0.010 |
Why?
|
| Calcium | 2 | 2009 | 5755 | 0.010 |
Why?
|
| Pain | 2 | 2009 | 4988 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 537 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2023 | 57776 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 1999 | 89 | 0.010 |
Why?
|
| Range of Motion, Articular | 2 | 1999 | 1578 | 0.010 |
Why?
|
| Liver | 1 | 1995 | 7475 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2009 | 6459 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2004 | 1142 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2014 | 4583 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 35425 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 2004 | 1173 | 0.010 |
Why?
|
| Weight-Bearing | 1 | 1999 | 515 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 9445 | 0.010 |
Why?
|
| Recurrence | 1 | 1988 | 8340 | 0.010 |
Why?
|
| Sex Differentiation | 1 | 1996 | 73 | 0.010 |
Why?
|
| Anterior Cruciate Ligament | 1 | 1999 | 415 | 0.010 |
Why?
|
| Mice | 2 | 2009 | 81201 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1998 | 13814 | 0.010 |
Why?
|
| Internet | 1 | 2007 | 3056 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 14561 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1995 | 1085 | 0.010 |
Why?
|
| Spermine Synthase | 1 | 1992 | 2 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 2850 | 0.010 |
Why?
|
| Eflornithine | 1 | 1992 | 31 | 0.010 |
Why?
|
| Spermidine | 1 | 1992 | 56 | 0.010 |
Why?
|
| Point Mutation | 1 | 1998 | 1624 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6313 | 0.010 |
Why?
|
| Spermine | 1 | 1992 | 70 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 798 | 0.010 |
Why?
|
| Diamines | 1 | 1992 | 59 | 0.010 |
Why?
|
| Inflammation | 1 | 2012 | 10637 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 1999 | 1828 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1995 | 811 | 0.010 |
Why?
|
| Ergocalciferols | 1 | 1992 | 110 | 0.010 |
Why?
|
| Calcifediol | 1 | 1992 | 166 | 0.010 |
Why?
|
| Bone Nails | 1 | 1992 | 219 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 15160 | 0.010 |
Why?
|
| Neurons | 1 | 2009 | 9340 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18034 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 11366 | 0.010 |
Why?
|
| Aging | 1 | 2009 | 8664 | 0.010 |
Why?
|
| CHO Cells | 1 | 1992 | 1409 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2009 | 12207 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 7721 | 0.010 |
Why?
|
| Hypercalcemia | 1 | 1992 | 409 | 0.010 |
Why?
|
| Disabled Persons | 1 | 1999 | 1212 | 0.010 |
Why?
|
| Bone Plates | 1 | 1992 | 468 | 0.010 |
Why?
|
| Cricetinae | 1 | 1992 | 2475 | 0.010 |
Why?
|
| Spleen | 1 | 1995 | 2362 | 0.010 |
Why?
|
| Heart Massage | 1 | 1968 | 30 | 0.000 |
Why?
|
| Carrier Proteins | 1 | 2001 | 5023 | 0.000 |
Why?
|
| Cholecalciferol | 1 | 1992 | 535 | 0.000 |
Why?
|
| Kidney | 1 | 2001 | 7184 | 0.000 |
Why?
|
| Hip Joint | 1 | 1992 | 1002 | 0.000 |
Why?
|
| Transfection | 1 | 1992 | 5895 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 20130 | 0.000 |
Why?
|
| Prognosis | 2 | 1999 | 29060 | 0.000 |
Why?
|
| Rats | 1 | 1995 | 24252 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1968 | 1470 | 0.000 |
Why?
|
| Stress, Psychological | 1 | 1992 | 4245 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1992 | 19233 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1992 | 12073 | 0.000 |
Why?
|
| Diet | 1 | 1992 | 7937 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1999 | 63107 | 0.000 |
Why?
|
| Hypoxia, Brain | 1 | 1968 | 133 | 0.000 |
Why?
|
| Electric Countershock | 1 | 1968 | 534 | 0.000 |
Why?
|
| Respiration, Artificial | 1 | 1968 | 2569 | 0.000 |
Why?
|